Case number 1:18-cv-01232
AstraZeneca LP et al v. Hisun Pharmaceutical Co., Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2020 | 1 | Complaint (22) |
| Dec 4, 2018 | 16 | Patent/Trademark Report to Commissioner (1) |
| Dec 4, 2018 | 15 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 12/3/2018. (nms) |
| Dec 4, 2018 | 16 | Consent Judgment (4) |
| Dec 4, 2018 | 16 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 46,276; 7,250,419; 7,265,124. (Attachments: # (1) Consent Judgment)(nms) |
| Nov 30, 2018 | 14 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) |
| Sep 11, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The waiver filed at D.I. 11 has been removed from the docket per counsel's request. The waiver will be refiled shortly indicating the party served is outside of the United States. (nms) |
| Sep 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] Stipulation and Proposed Order (*Reset Answer Deadlines: Hisun Pharmaceuticals USA, Inc. answer due 12/3/2018). Signed by Judge Richard G. Andrews on 9/11/2018. (nms) |
| Sep 11, 2018 | 13 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca AB: (Silver, Daniel) |
| Sep 10, 2018 | 12 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) |
| Aug 24, 2018 | 9 | Declaration (2) |
| Aug 24, 2018 | 9 | Exhibit A-B (6) |
| Aug 24, 2018 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca AB. Hisun Pharmaceuticals USA, Inc. served on 8/22/2018, answer due 9/12/2018. (Silver, Daniel) |
| Aug 24, 2018 | 9 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Hisun Pharmaceutical (Hangzhou) Co., Ltd. made on August 22, 2018, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # (1) Exhibits A-B)(Silver, Daniel) Modified on 8/24/2018 (nms). |
| Aug 15, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Aug 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hisun Pharmaceutical (Hangzhou) Co., Ltd. on 8/13/2018; Hisun Pharmaceuticals USA, Inc. on 8/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
| Aug 10, 2018 | 1 | Exhibit A - D (68) |
| Aug 10, 2018 | 1 | Civil Cover Sheet (2) |
| Aug 10, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Aug 10, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 12/28/2020. (crb) |
| Aug 10, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,276 ;7,250,419 ;7,265,124. (crb) |
| Aug 10, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca LP filed by AstraZeneca LP. (crb) |
| Aug 10, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (crb) |
| Aug 10, 2018 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca UK Limited filed by AstraZeneca UK Limited. (crb) |
| Aug 10, 2018 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (crb) |
| Aug 10, 2018 | 1 | Main Document (22) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Hisun Pharmaceutical (Hangzhou) Co., Ltd., Hisun Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2437867.) - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca AB. (Attachments: # (1) Exhibit A - D, # (2) Civil Cover Sheet)(crb) |
| Aug 10, 2018 | 1 | Complaint* (1) |
